{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:52:05Z","timestamp":1781506325061,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ningbo Clinical Research Center for Urological Disease","award":["No.2019A21001"],"award-info":[{"award-number":["No.2019A21001"]}]},{"name":"Ningbo Top Medical and Health Research Program","award":["No.2022020203"],"award-info":[{"award-number":["No.2022020203"]}]},{"name":"Zhejiang Engineering Research Center of Innovative technologies and diagnostic and therapeutic equipment for urinary system diseases"},{"DOI":"10.13039\/501100004731","name":"Zhejiang Natural Science Foundation","doi-asserted-by":"crossref","award":["No.LTGY24H160005"],"award-info":[{"award-number":["No.LTGY24H160005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09794-y","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:55:15Z","timestamp":1781502915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer"],"prefix":"10.1007","volume":"74","author":[{"given":"Min","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangchen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"9685","key":"9794_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet. 2009;374(9685):239\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(09)60491-8.","journal-title":"Lancet"},{"issue":"3","key":"9794_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"10061","key":"9794_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer Lancet. 2016;388(10061):2796\u2013810. https:\/\/doi.org\/10.1016\/S0140-6736(16)30512-8.","journal-title":"Bladder cancer Lancet"},{"issue":"4","key":"9794_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAP.0000000000000235","volume":"26","author":"M Akhtar","year":"2019","unstructured":"Akhtar M, Al-Bozom IA, Ben Gashir M, Taha NM. Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there? Adv Anat Pathol. 2019;26(4):251\u20136. https:\/\/doi.org\/10.1097\/PAP.0000000000000235.","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"9794_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81(1):75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010.","journal-title":"Eur Urol"},{"key":"9794_CR6","doi-asserted-by":"publisher","unstructured":"Yurchenco PD. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol. 2011;3(2). https:\/\/doi.org\/10.1101\/cshperspect.a004911.","DOI":"10.1101\/cshperspect.a004911"},{"issue":"3","key":"9794_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/EBC20180071","volume":"63","author":"A Gatseva","year":"2019","unstructured":"Gatseva A, Sin YY, Brezzo G, Van Agtmael T. Basement membrane collagens and disease mechanisms. Essays Biochem. 2019;63(3):297\u2013312. https:\/\/doi.org\/10.1042\/EBC20180071.","journal-title":"Essays Biochem"},{"key":"9794_CR8","doi-asserted-by":"publisher","unstructured":"Miller RT. Mechanical properties of basement membrane in health and disease. Matrix Biol. 2017;57\u201358:366\u2009\u2013\u200973. https:\/\/doi.org\/10.1016\/j.matbio.2016.07.001","DOI":"10.1016\/j.matbio.2016.07.001"},{"issue":"1\u20132","key":"9794_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/critrevoncog.v18.i1-2.40","volume":"18","author":"TN Seyfried","year":"2013","unstructured":"Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18(1\u20132):43\u201373. https:\/\/doi.org\/10.1615\/critrevoncog.v18.i1-2.40.","journal-title":"Crit Rev Oncog"},{"issue":"5","key":"9794_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402\u201318. https:\/\/doi.org\/10.1016\/j.apsb.2015.07.005.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"9794_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.eururo.2015.01.032","volume":"68","author":"LA Kluth","year":"2015","unstructured":"Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, et al. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. Eur Urol. 2015;68(2):238\u201353. https:\/\/doi.org\/10.1016\/j.eururo.2015.01.032.","journal-title":"Eur Urol"},{"issue":"1","key":"9794_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12894-025-01914-4","volume":"25","author":"H Dai","year":"2025","unstructured":"Dai H, Zhao K, Zhao Y, Jiang K, Hang Z, Huang X, et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 2025;25(1):229. https:\/\/doi.org\/10.1186\/s12894-025-01914-4.","journal-title":"BMC Urol"},{"issue":"1","key":"9794_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Yu Z, Zhao Y, Jiang K, Hang Z, Huang X, et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56. https:\/\/doi.org\/10.1186\/s13062-025-00650-x.","journal-title":"Biol Direct"},{"issue":"1","key":"9794_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41746-025-01930-6","volume":"8","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu H, Ren J, Ren M. Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology. NPJ Digit Med. 2025;8(1):524. https:\/\/doi.org\/10.1038\/s41746-025-01930-6.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"9794_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","volume":"26","author":"H Dai","year":"2026","unstructured":"Dai H, Zhang X, Yin L, Chen H, Liu K, Li J, et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int. 2026;26(1):15. https:\/\/doi.org\/10.1186\/s12935-025-04133-x.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"9794_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017;18(1):248\u201362. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.019.","journal-title":"Cell Rep"},{"issue":"3","key":"9794_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"9794_CR18","doi-asserted-by":"publisher","unstructured":"Wronski P, Wronski S, Kurant M, Malinowski B, Wicinski M. Curcumin may prevent basement membrane disassembly by matrix metalloproteinases and progression of the bladder cancer. Nutrients. 2021;14(1). https:\/\/doi.org\/10.3390\/nu14010032.","DOI":"10.3390\/nu14010032"},{"issue":"8","key":"9794_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.kjms.2012.12.003","volume":"29","author":"SG Kang","year":"2013","unstructured":"Kang SG, Ha YR, Ko YH, Kang SH, Joo KJ, Cho HY, et al. Effect of laminin 332 on motility and invasion in bladder cancer. Kaohsiung J Med Sci. 2013;29(8):422\u20139. https:\/\/doi.org\/10.1016\/j.kjms.2012.12.003.","journal-title":"Kaohsiung J Med Sci"},{"issue":"12","key":"9794_CR20","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/cas.12832","volume":"106","author":"M Kamada","year":"2015","unstructured":"Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, et al. Urinary laminin-gamma2 is a novel biomarker of non-muscle invasive urothelial carcinoma. Cancer Sci. 2015;106(12):1730\u20137. https:\/\/doi.org\/10.1111\/cas.12832.","journal-title":"Cancer Sci"},{"issue":"1","key":"9794_CR21","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1186\/s12885-022-10102-8","volume":"22","author":"L Gao","year":"2022","unstructured":"Gao L, Ren R, Shen J, Hou J, Ning J, Feng Y, et al. Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer. BMC Cancer. 2022;22(1):1016. https:\/\/doi.org\/10.1186\/s12885-022-10102-8.","journal-title":"BMC Cancer"},{"key":"9794_CR22","doi-asserted-by":"publisher","first-page":"112087","DOI":"10.1016\/j.intimp.2024.112087","volume":"133","author":"W Zhang","year":"2024","unstructured":"Zhang W, Chen L, Lu X, Dong X, Feng M, Tu Y, et al. EFHD2 regulates T cell receptor signaling and modulates T helper cell activation in early sepsis. Int Immunopharmacol. 2024;133:112087. https:\/\/doi.org\/10.1016\/j.intimp.2024.112087.","journal-title":"Int Immunopharmacol"},{"issue":"19","key":"9794_CR23","doi-asserted-by":"publisher","first-page":"30766","DOI":"10.18632\/oncotarget.15403","volume":"8","author":"D Muraoka","year":"2017","unstructured":"Muraoka D, Seo N, Hayashi T, Hyuga-Amaike C, Okamori K, Tawara I, et al. Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8\u2009+\u2009T cells by preventing terminal effector differentiation. Oncotarget. 2017;8(19):30766\u201380. https:\/\/doi.org\/10.18632\/oncotarget.15403.","journal-title":"Oncotarget"},{"issue":"2","key":"9794_CR24","doi-asserted-by":"publisher","first-page":"114885","DOI":"10.1016\/j.yexcr.2026.114885","volume":"455","author":"K He","year":"2026","unstructured":"He K, Lin C, Wang H, Wu H, Yin S, Tao C, et al. The circ-GLG1\/miR-346\/KCNJ9 axis drives malignant progression of bladder cancer by modulating KCNJ9 expression. Exp Cell Res. 2026;455(2):114885. https:\/\/doi.org\/10.1016\/j.yexcr.2026.114885.","journal-title":"Exp Cell Res"},{"issue":"8","key":"9794_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/mc.23741","volume":"63","author":"F Chen","year":"2024","unstructured":"Chen F, Lin J, Kang R, Tang D, Liu J. Alkaliptosis induction counteracts paclitaxel-resistant ovarian cancer cells via ATP6V0D1-mediated ABCB1 inhibition. Mol Carcinog. 2024;63(8):1515\u201327. https:\/\/doi.org\/10.1002\/mc.23741.","journal-title":"Mol Carcinog"},{"key":"9794_CR26","doi-asserted-by":"publisher","unstructured":"Chang CF, Chen LC, Chen YT, Huang CY, Yu CC, Lin VC, et al. Unveiling DENND2D as a novel prognostic biomarker for prostate cancer recurrence: from gene to prognosis. Biomedicines. 2024;13(1). https:\/\/doi.org\/10.3390\/biomedicines13010025.","DOI":"10.3390\/biomedicines13010025"},{"key":"9794_CR27","doi-asserted-by":"publisher","unstructured":"Salazar C, Yanez O, Elorza AA, Cortes N, Garcia-Beltran O, Tiznado W, et al. Biosystem analysis of the hypoxia inducible domain family member 2a: implications in cancer biology. Genes (Basel). 2020;11(2). https:\/\/doi.org\/10.3390\/genes11020206.","DOI":"10.3390\/genes11020206"},{"key":"9794_CR28","doi-asserted-by":"publisher","first-page":"1557223","DOI":"10.3389\/fimmu.2025.1557223","volume":"16","author":"H Zhu","year":"2025","unstructured":"Zhu H, Zhao Y, Wang Y, Wei G, Liu J. Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies. Front Immunol. 2025;16:1557223. https:\/\/doi.org\/10.3389\/fimmu.2025.1557223.","journal-title":"Front Immunol"},{"key":"9794_CR29","doi-asserted-by":"publisher","first-page":"1623859","DOI":"10.3389\/fimmu.2025.1623859","volume":"16","author":"J Sun","year":"2025","unstructured":"Sun J, Ren S, Zhao Q, He J, Wang Y, Ren M. Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment. Front Immunol. 2025;16:1623859. https:\/\/doi.org\/10.3389\/fimmu.2025.1623859.","journal-title":"Front Immunol"},{"key":"9794_CR30","doi-asserted-by":"publisher","unstructured":"Bozyk A, Wojas-Krawczyk K, Krawczyk P, Milanowski J. Tumor microenvironment-a short review of cellular and interaction diversity. Biology (Basel). 2022;11(6). https:\/\/doi.org\/10.3390\/biology11060929.","DOI":"10.3390\/biology11060929"},{"key":"9794_CR31","doi-asserted-by":"publisher","first-page":"1235884","DOI":"10.3389\/fimmu.2023.1235884","volume":"14","author":"J van Dorp","year":"2023","unstructured":"van Dorp J, van der Heijden MS. The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition. Front Immunol. 2023;14:1235884. https:\/\/doi.org\/10.3389\/fimmu.2023.1235884.","journal-title":"Front Immunol"},{"key":"9794_CR32","doi-asserted-by":"publisher","first-page":"105880","DOI":"10.1016\/j.intimp.2019.105880","volume":"76","author":"L Sharifi","year":"2019","unstructured":"Sharifi L, Nowroozi MR, Amini E, Arami MK, Ayati M, Mohsenzadegan M. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol. 2019;76:105880. https:\/\/doi.org\/10.1016\/j.intimp.2019.105880.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"9794_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.urolonc.2010.08.009","volume":"30","author":"CT Lin","year":"2012","unstructured":"Lin CT, Tung CL, Tsai YS, Shen CH, Jou YC, Yu MT, et al. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma. Urol Oncol. 2012;30(5):680\u20137. https:\/\/doi.org\/10.1016\/j.urolonc.2010.08.009.","journal-title":"Urol Oncol"},{"key":"9794_CR34","doi-asserted-by":"publisher","first-page":"115301","DOI":"10.1016\/j.intimp.2025.115301","volume":"164","author":"J Xu","year":"2025","unstructured":"Xu J, Wang G, Wang M, Xu X, Xu Y, Zhang C, et al. Pedunculoside regulates tumor immune microenvironment and malignant characteristics of bladder cancer by TRAF6 mediated M2 macrophage polarization. Int Immunopharmacol. 2025;164:115301. https:\/\/doi.org\/10.1016\/j.intimp.2025.115301.","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"9794_CR35","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1158\/1078-0432.CCR-17-1004","volume":"23","author":"VG Martinez","year":"2017","unstructured":"Martinez VG, Rubio C, Martinez-Fernandez M, Segovia C, Lopez-Calderon F, Garin MI, et al. BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer. Clin Cancer Res. 2017;23(23):7388\u201399. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1004.","journal-title":"Clin Cancer Res"},{"issue":"7492","key":"9794_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research N","year":"2014","unstructured":"Cancer Genome Atlas Research N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315\u201322. https:\/\/doi.org\/10.1038\/nature12965.","journal-title":"Nature"},{"issue":"2","key":"9794_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajur.2024.09.006","volume":"12","author":"Y Li","year":"2025","unstructured":"Li Y, Huang S, Ju W, Lu D, Sun J, Zhan W, et al. Deciphering riddles in molecular subtyping of bladder cancer. Asian J Urol. 2025;12(2):217\u201331. https:\/\/doi.org\/10.1016\/j.ajur.2024.09.006.","journal-title":"Asian J Urol"},{"issue":"9","key":"9794_CR38","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1172\/JCI83871","volume":"125","author":"Y Yang","year":"2015","unstructured":"Yang Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest. 2015;125(9):3335\u20137. https:\/\/doi.org\/10.1172\/JCI83871.","journal-title":"J Clin Invest"},{"issue":"1","key":"9794_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imm.12675","volume":"150","author":"E Reeves","year":"2017","unstructured":"Reeves E, James E. Antigen processing and immune regulation in the response to tumours. Immunology. 2017;150(1):16\u201324. https:\/\/doi.org\/10.1111\/imm.12675.","journal-title":"Immunology"},{"key":"9794_CR40","doi-asserted-by":"publisher","unstructured":"Tan AC, Bagley SJ, Wen PY, Lim M, Platten M, Colman H, et al. Systematic review of combinations of targeted or immunotherapy in advanced solid tumors. J Immunother Cancer. 2021;9(7). https:\/\/doi.org\/10.1136\/jitc-2021-002459.","DOI":"10.1136\/jitc-2021-002459"},{"key":"9794_CR41","doi-asserted-by":"publisher","first-page":"1212476","DOI":"10.3389\/fimmu.2023.1212476","volume":"14","author":"R Rui","year":"2023","unstructured":"Rui R, Zhou L, He S. Cancer immunotherapies: advances and bottlenecks. Front Immunol. 2023;14:1212476. https:\/\/doi.org\/10.3389\/fimmu.2023.1212476.","journal-title":"Front Immunol"},{"issue":"8","key":"9794_CR42","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016;27(8):1482\u201392. https:\/\/doi.org\/10.1093\/annonc\/mdw168.","journal-title":"Ann Oncol"},{"issue":"25","key":"9794_CR43","doi-asserted-by":"publisher","first-page":"e2300110","DOI":"10.1002\/advs.202300110","volume":"10","author":"H Li","year":"2023","unstructured":"Li H, Chen J, Li Z, Chen M, Ou Z, Mo M, et al. S100A5 Attenuates Efficiency of Anti-PD-L1\/PD-1 Immunotherapy by Inhibiting CD8(+) T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma. Adv Sci (Weinh). 2023;10(25):e2300110. https:\/\/doi.org\/10.1002\/advs.202300110.","journal-title":"Adv Sci (Weinh)"},{"key":"9794_CR44","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, et al. Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett. 2024;593:216964. https:\/\/doi.org\/10.1016\/j.canlet.2024.216964.","journal-title":"Cancer Lett"},{"issue":"1","key":"9794_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12672-025-02093-2","volume":"16","author":"J Gu","year":"2025","unstructured":"Gu J, Wang Y, Zhang H, Gu H, Zhu H. SIGLEC1 has the potential to be an immune-related prognostic indicator in colon adenocarcinoma: a study based on transcriptomic data and Mendelian randomization analysis. Discov Oncol. 2025;16(1):324. https:\/\/doi.org\/10.1007\/s12672-025-02093-2.","journal-title":"Discov Oncol"},{"issue":"1","key":"9794_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai H, Zhang X, Zhao Y, Nie J, Hang Z, Huang X, et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas. 2025;162(1):42. https:\/\/doi.org\/10.1186\/s41065-025-00409-4.","journal-title":"Hereditas"},{"issue":"1","key":"9794_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, Wang X, Wu Q, Tan Y, Shen H, Gu Y, et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell Div. 2025;20(1):27. https:\/\/doi.org\/10.1186\/s13008-025-00172-y.","journal-title":"Cell Div"},{"key":"9794_CR48","doi-asserted-by":"publisher","first-page":"1573815","DOI":"10.3389\/fimmu.2025.1573815","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhu H, Luo Y, Xie T, Hu Y, Yan Z, et al. ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis. Front Immunol. 2025;16:1573815. https:\/\/doi.org\/10.3389\/fimmu.2025.1573815.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09794-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09794-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T05:55:16Z","timestamp":1781502916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09794-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9794"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09794-y","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}}],"article-number":"59"}}